Effect of acellular dermal matrix device(J-1) in treating congenital giant pigmented nevi

Status

Active, not recruiting

Phases

Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR-PRCS-13003511

Enrollment

Unknown

Registered

2013-02-13

Start date

2013-03-03

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

giant nevus,large area full thickness skin damage

Interventions

A:treat by acellular dermal matrix device

Eligibility

Sex/Gender

All

Age

No minimum to 10 Years

Inclusion criteria

Inclusion criteria: 1. Giant nevus; 2. Large area full thickness skin damage; 3. Having signed the informed consent.

Exclusion criteria

Exclusion criteria: 1. With heart disease, the assembly of persons with heart pacemakers; 2. Pregnant woman; 3. With ulceration, or infection in the treatment area;

Design outcomes

Primary

Measure	Time frame
location;size of lesion;	—

Countries

China

Contacts

Public ContactXiangdong Qi

dr_qi@163.com+86 020 31998418

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026